Filter Results

Clear All Filters

Displaying 7 results for

GO
Search Filters: Policy cancel Social and Behavioral Health cancel West Virginia cancel New York cancel

Oyez! Oyez! Oyez! Public Health in the Courts

Blog,

There are a number of court cases playing out across the country that could affect the options state and territorial health officials have to limit the spread of disease and promote health and well-being.

Harm Reduction Policies Can Prevent Overdose Fatalities

Blog,

Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e

2022 Legislative Session Update: Part Two

Blog,
STIs,
HIV,
PFAS,

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

Jurisdictions Moving Many ASTHO Essential Tobacco Control Policies Forward

Blog,
Guam,
Iowa,

Over the past several years, states and jurisdictions have continued to implement important policies to reduce tobacco and nicotine use, including increasing tobacco prices, expanding areas deemed “smoke-free,” limiting the sale of ...

Proposed Vaccination Laws to Watch in the New Year

Blog,
STIs,
HIV,
PFAS,

Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death among children and adults. The COVID-19 ...

2023 Legislative Session Update: Part One

Blog,
STIs,
HIV,
PFAS,
Guam,
Utah,

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Guam,
Utah,
Blog,

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...